A Series of Patients With Myocarditis Following SARS-CoV-2 Vaccination With mRNA-1279 and BNT162b2
Dickey, John B. Albert, Elisabeth Badr, Mai Laraja, Kristin M. Sena, Laureen M. Gerson, David S. Saucedo, Jason E. Qureshi, Waqas T Aurigemma, Gerard P.
Dickey, John B.
Albert, Elisabeth
Badr, Mai
Laraja, Kristin M.
Sena, Laureen M.
Gerson, David S.
Saucedo, Jason E.
Qureshi, Waqas T
Aurigemma, Gerard P.
Citations
Altmetric:
Student Authors
Faculty Advisor
Academic Program
Document Type
Response or Comment
Publication Date
2021-09-01
Subject Area
Collections
Embargo Expiration Date
Link to Full Text
Abstract
Wide availability of the 3 vaccines approved by the U.S. Food and Drug Administration for emergency use against SARS-CoV-2 has led to reports of adverse reactions not seen during clinical trials: We now report a series of patients who developed CMR-proven myocarditis shortly after vaccination.
Source
Dickey JB, Albert E, Badr M, Laraja KM, Sena LM, Gerson DS, Saucedo JE, Qureshi W, Aurigemma GP. A Series of Patients With Myocarditis Following SARS-CoV-2 Vaccination With mRNA-1279 and BNT162b2. JACC Cardiovasc Imaging. 2021 Sep;14(9):1862-1863. doi: 10.1016/j.jcmg.2021.06.003. Epub 2021 Jun 16. PMID: 34246585; PMCID: PMC8219373. Link to article on publisher's site
Year of Medical School at Time of Visit
Sponsors
Dates of Travel
DOI
10.1016/j.jcmg.2021.06.003
Permanent Link to this Item
PubMed ID
34246585